dalbavancin

This template is part of the ArticlePlaceholder extension. If you want to adjust it, please consider making your changes upstream.

no tipo 'e

type of chemical entity

sottoclasse di

lipoglycopeptides^[15]

dalbavancin

è ausato comme

farmaco^[16]

struttura chimica

massa

1 814,609 unità e' massa atomeca^[5]

formula chimica

C₈₈H₁₀₀Cl₂N₁₀O₂₈^[5]

SMILES canonico

CC(C)CCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=CC(=CC(=C7C8=C(C=CC(=C8)C(C(=O)N6)NC(=O)C4NC(=O)C9C1=CC(=CC(=C1Cl)O)OC1=C(C=CC(=C1)C(C(=O)NC(CC1=CC=C(O3)C=C1)C(=O)N9)NC)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O^[5]

SMILES isomerico

CC(C)CCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)[C@H]([C@H]6C(=O)N[C@@H](C7=CC(=CC(=C7C8=C(C=CC(=C8)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]9C1=CC(=CC(=C1Cl)O)OC1=C(C=CC(=C1)[C@H](C(=O)N[C@H](CC1=CC=C(O3)C=C1)C(=O)N9)NC)O)O)O[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O^[5]

dose giornaliera definita

1,5 grammo^[17]

via di somministrazione: parenteral route of administration

principio attivo in

Dalvance^[18]

Denominazione Comune Internazionale

dalbavancin^[2]

condizione medica trattata

cellulite^[19]

ruolo del soggetto

protein synthesis inhibitor^[20]

antibiotico^[21]

battericida^[22]

‎WHO Aware Classification

reserve^[23]

Riferimento

1. ↑ ^{1,0 1,1} NDF-RT, 19 Jen 2016, Lengua ngrese, DALBAVANCIN, N0000171775
2. ↑ ^{2,0 2,1 2,2 2,3} ChEBI, 9 ott 2016, Lengua ngrese, dalbavancin, 82721
3. ↑ ^{3,0 3,1 3,2} Global Substance Registration System, 15 Fre 2018, 808UI9MS5K
4. ↑ CAS Common Chemistry, 10 Abb 2021, KGPGQDLTDHGEGT-SZUNQUCBSA-N, https://commonchemistry.cas.org/detail?cas_rn=171500-79-1
5. ↑ ^{5,0 5,1 5,2 5,3 5,4 5,5} PubChem, 18 Nuv 2016, Lengua ngrese, 16134627, Dalvance
6. ↑ ^{6,0 6,1} UniChem
7. ↑ OpenAlex, 26 Jen 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
8. ↑ ^{8,0 8,1} ChEMBL, 18 Nuv 2016, Lengua ngrese, DALBAVANCIN, CHEMBL3301669
9. ↑ ChEBI release 2020-09-01
10. ↑ ^{10,0 10,1} DrugBank, Lengua ngrese, 17 Nuv 2015, 06219, Dalbavancin
11. ↑ https://www.drugbank.ca/releases/latest#open-data, Abbrile 2018
12. ↑ Medical Subject Headings, 14 Màr 2018, C469289
13. ↑ ChemSpider, 18 Nuv 2016, Lengua ngrese, 17290939, 17290939
14. ↑ inferred from SMILES
15. ↑ N0000171775, 27 Fre 2018, NDF-RT
16. ↑ DrugBank, Lengua ngrese, 17 Nuv 2015, Dalbavancin, 06219
17. ↑ https://www.whocc.no/atc_ddd_index/?code=J01XA04
18. ↑ RxNorm, 1539244, 15 Fre 2018
19. ↑ Drug Indications Extracted from FAERS, 2 ott 2018
20. ↑ N0000171775, 5 Màr 2018, NDF-RT
21. ↑ Medical Subject Headings, 15 Màr 2018, C469289
22. ↑ ChEBI, 82721
23. ↑ 2023 ‎AWaRe classification‎